Come up with a name for your new list and we'll add to it:
NovImmune raised a round of funding on October 15, 2012. Investors include
Seventh Framework Programme.
NovImmune is a biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders, and cancer.…